{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:07:08Z","timestamp":1789103228911,"version":"build-2803163510"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Sarcopenia is a common geriatric syndrome that substantially impairs physical function, mobility, and quality of life in older patients with type 2 diabetes mellitus. However, evidence regarding factors associated with sarcopenia in this population remains fragmented and inconsistent, and previous studies have often included mixed-age populations or provided limited quantitative synthesis specifically focused on older adults. Therefore, this systematic review and meta-analysis aimed to comprehensively identify and quantify the associations between clinical factors and sarcopenia in older patients with type 2 diabetes mellitus, thereby providing age-specific evidence for clinical assessment, early identification, and individualized management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Relevant studies examining factors associated with sarcopenia in older patients with type 2 diabetes mellitus were systematically searched in six databases: PubMed, Web of Science, Embase, the Cochrane Library, CNKI, and Wanfang Data. The search covered the period from database inception to January 2026. Study characteristics, participant characteristics, potential associated factors, and sarcopenia-related outcomes were extracted. The methodological quality of the included cross-sectional studies was assessed using the AHRQ checklist. Meta-analyses were conducted using Review Manager version 5.3. Continuous variables were pooled using mean differences or standardized mean differences, and dichotomous variables were pooled using odds ratios. Publication bias and small-study effects were assessed using funnel plots and Egger\u2019s regression test when at least 10 studies were available for a given outcome. For outcomes with substantial heterogeneity, REML-based 95% prediction intervals and exploratory univariable meta-regression analyses were conducted when sufficient data were available. The certainty of evidence for each pooled outcome was assessed using the GRADE approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 19 cross-sectional studies involving 4,727 older patients with type 2 diabetes mellitus were included. The included studies were of moderate to high methodological quality, with no low-quality studies identified. Sarcopenia was diagnosed using different criteria, including the Asian Working Group for Sarcopenia 2014 criteria, the AWGS 2019 criteria, the European Working Group on Sarcopenia in Older People criteria, and the revised EWGSOP2 criteria. Meta-analysis showed that patients with sarcopenia were significantly older than those without sarcopenia, and had a longer duration of diabetes, higher fasting blood glucose levels, higher HbA1c levels, lower body mass index, and lower hemoglobin levels. No statistically significant associations were observed for male sex, total cholesterol, triglycerides, HDL-C, LDL-C, serum albumin, 25(OH)D, hypertension, smoking exposure, insulin therapy, or coronary\/ischemic heart disease. Although sensitivity analyses generally supported the directional stability of the main findings, substantial heterogeneity remained for several outcomes, and all REML-based 95% prediction intervals crossed the null value. Exploratory meta-regression identified geographic region as a significant moderator only for HbA1c. Egger\u2019s tests did not indicate statistically significant small-study effects for outcomes with sufficient studies. The certainty of evidence was rated as low for HDL-C, hypertension, and insulin therapy and as very low for all other pooled outcomes, primarily because of the cross-sectional study design, substantial inconsistency, and imprecision.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In conclusion, older age, lower BMI, longer diabetes duration, higher fasting blood glucose, higher HbA1c, and lower hemoglobin levels were associated with sarcopenia in older patients with type 2 diabetes mellitus. However, the certainty of evidence was low to very low, and substantial heterogeneity and prediction intervals crossing the null value indicate that the magnitude and presence of these associations may vary across populations and clinical settings. These findings may heighten clinical suspicion during guideline-based sarcopenia assessment but should not be regarded as evidence of independent prediction, validated screening thresholds, or causality. Future prospective studies with standardized measurements and comprehensive adjustment for confounders are required.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:ext-link>\n                      , identifier CRD420261301123.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1933664","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:30:42Z","timestamp":1789101042000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors associated with sarcopenia in elderly patients with type 2 diabetes mellitus"],"prefix":"10.3389","volume":"17","author":[{"given":"Ziqi","family":"Cao","sequence":"first","affiliation":[{"name":"Wangqi Academy, National Institute of TCM Constitution and Preventive Medicine, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[{"name":"Wangqi Academy, National Institute of TCM Constitution and Preventive Medicine, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Gao","sequence":"additional","affiliation":[{"name":"Wangqi Academy, National Institute of TCM Constitution and Preventive Medicine, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzheng","family":"Tang","sequence":"additional","affiliation":[{"name":"Wangqi Academy, National Institute of TCM Constitution and Preventive Medicine, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Wangqi Academy, National Institute of TCM Constitution and Preventive Medicine, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Ji","sequence":"additional","affiliation":[{"name":"Wangqi Academy, National Institute of TCM Constitution and Preventive Medicine, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshuai","family":"Li","sequence":"additional","affiliation":[{"name":"Wangqi Academy, National Institute of TCM Constitution and Preventive Medicine, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(25)00299-2","article-title":"11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050","volume":"14","author":"Genitsaridi","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3760\/cma.j.cn112138-20211027-00751","article-title":"Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China: 2022 edition","volume":"61","year":"2022","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169548","article-title":"Health outcomes of sarcopenia: a systematic review and meta-analysis","volume":"12","author":"Beaudart","year":"2017","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/srep38937","article-title":"Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12902-025-01935-y","article-title":"Sarcopenia in type 2 diabetes mellitus among Asian populations: prevalence and risk factors based on AWGS-2019: a systematic review and meta-analysis","volume":"25","author":"Yogesh","year":"2025","journal-title":"BMC Endocr Disord"},{"key":"B8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13098-021-00707-7","article-title":"The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"13","author":"Ai","year":"2021","journal-title":"Diabetol Metab Syndr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/jdi.70185","article-title":"Prevalence and risk factors of sarcopenia in Asian adults with type 2 diabetes: a systematic review and meta-analysis","volume":"17","author":"Wu","year":"2026","journal-title":"J Diabetes Investig"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"B12","article-title":"Methods guide for effectiveness and comparative effectiveness reviews [Internet","volume-title":"Agency for Healthcare Research and Quality (US)","year":"2008"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1104931","article-title":"Using machine learning to predict lymph node metastasis in patients with renal cell carcinoma: a population-based study","volume":"11","author":"Zhang","year":"2023","journal-title":"Front Public Health"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2023.07.002","article-title":"Novel model for cancer-specific survival of patients with pulmonary sarcomatoid carcinoma: a population-based analysis and external validation","volume":"47","author":"Yi","year":"2024","journal-title":"Asian J Surg"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6794","article-title":"Prognostic nomogram and epidemiological analysis for lung atypical carcinoid: a SEER database and external validation study","volume":"13","author":"Yi","year":"2024","journal-title":"Cancer Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1105224","article-title":"Individual risk and prognostic value prediction by machine learning for distant metastasis in pulmonary sarcomatoid carcinoma: a large cohort study based on the SEER database and the Chinese population","volume":"13","author":"Yi","year":"2023","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/8001899","article-title":"Development and external validation of machine learning-based models for predicting lung metastasis in kidney cancer: a large population-based study","volume":"2023","author":"Yi","year":"2023","journal-title":"Int J Clin Pract"},{"key":"B18","doi-asserted-by":"publisher","first-page":"14827","DOI":"10.1038\/s41598-023-40779-1","article-title":"Prediction of lung papillary adenocarcinoma-specific survival using ensemble machine learning models","volume":"13","author":"Xia","year":"2023","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s40001-025-02606-3","article-title":"Intelligent predictive risk assessment and management of sarcopenia in chronic disease patients using machine learning and a web-based tool","volume":"30","author":"Rong","year":"2025","journal-title":"Eur J Med Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1005-3697.2025.08.011","article-title":"Correlation between serum CRP, uric acid, 25(OH)D levels and sarcopenia in elderly patients with type 2 diabetes mellitus","volume":"40","author":"Yang","year":"2025","journal-title":"J North Sichuan Med Coll"},{"key":"B21","first-page":"96","article-title":"Investigation on nutritional status and analysis of influencing factors for sarcopenia in elderly patients with type 2 diabetes mellitus","volume":"31","author":"Duan","year":"2025","journal-title":"Food Nutr China"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.19870\/j.cnki.11-3716\/ts.2024.12.001","article-title":"Correlation between serum vitamin D levels and sarcopenia in elderly patients with type 2 diabetes mellitus","volume":"30","author":"Wang","year":"2024","journal-title":"Food Nutr China"},{"key":"B23","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3969\/j.issn.1003-9198.2019.08.013","article-title":"Prevalence and influencing factors of sarcopenia in elderly patients with type 2 diabetes mellitus","volume":"33","author":"Zhang","year":"2019","journal-title":"Pract Geriatrics"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.19485\/j.cnki.issn2096-5087.2019.06.010","article-title":"Analysis of influencing factors for sarcopenia in elderly patients with type 2 diabetes mellitus","volume":"31","author":"Wang","year":"2019","journal-title":"Prev Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3969\/j.issn.1671-6450.2024.02.011","article-title":"Correlation analysis between serum Metrnl and E-FABP levels and sarcopenia in elderly patients with type 2 diabetes mellitus","volume":"23","author":"Huang","year":"2024","journal-title":"J Difficult Complicated cases"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1674-7593.2022.04.013","article-title":"Influencing factors for the occurrence of sarcopenia in elderly patients with type 2 diabetes mellitus","volume":"43","author":"Tian","year":"2022","journal-title":"Int J Geriatrics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.16050\/j.cnki.issn1674-6309.2022.11.010","article-title":"Relationship between serum ferritin, 25(OH)D levels and sarcopenia in elderly patients with type 2 diabetes mellitus","volume":"44","author":"Xu","year":"2022","journal-title":"J Ningxia Med Univ"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.16658\/j.cnki.1672-4062.2022.19.043","article-title":"Prevalence and influencing factors of sarcopenia in elderly hospitalized patients with type 2 diabetes mellitus","volume":"25","author":"Chen","year":"2022","journal-title":"Diabetes New World"},{"key":"B29","article-title":"Study on influencing factors of sarcopenia in elderly hospitalized patients with type 2 diabetes mellitus","volume":"23","author":"Cai","year":"2021","journal-title":"Chin J Geriatric Heart Brain Vessel Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-024-01504-5","article-title":"Evaluating the prevalence and risk factors of sarcopenia in elderly patients with type 2 diabetes mellitus in a Chinese hospital setting","volume":"23","author":"Zou","year":"2024","journal-title":"J Diabetes Metab Disord"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13792","article-title":"Sarcopenia is associated with the Geriatric Nutritional Risk Index in elderly patients with poorly controlled type 2 diabetes mellitus","volume":"13","author":"Matsuura","year":"2022","journal-title":"J Diabetes Investig"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233299","article-title":"The prevalence and factors associated with sarcopenia among community living elderly with type 2 diabetes mellitus in primary care clinics in Malaysia","volume":"15","author":"Sazlina","year":"2020","journal-title":"PloS One"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018708","article-title":"A cross-sectional study: associations between sarcopenia and clinical characteristics of patients with type 2 diabetes","volume":"99","author":"Cui","year":"2020","journal-title":"Med (Baltimore)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00271","article-title":"A high serum cortisol\/DHEA-S ratio is a risk factor for sarcopenia in elderly diabetic patients","volume":"3","author":"Yanagita","year":"2019","journal-title":"J Endocr Soc"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-018-1137-y","article-title":"Evaluation of oxidative stress parameters and antioxidant status in plasma and erythrocytes of elderly diabetic patients with sarcopenia","volume":"23","author":"K\u00fc\u00e7\u00fckdiler","year":"2019","journal-title":"J Nutr Health Aging"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1155\/ije\/7492307","article-title":"Evaluation of the relationship between sarcopenia and the Geriatric Nutritional Risk Index in elderly patients with type 2 diabetes mellitus","volume":"2025","author":"Calim","year":"2025","journal-title":"Int J Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2020.110835","article-title":"Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus","volume":"132","author":"de Freitas","year":"2020","journal-title":"Exp Gerontol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-017-0339-6","article-title":"Sarcopenia in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factors","volume":"9","author":"Murata","year":"2018","journal-title":"Diabetol Int"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155236","article-title":"Role of age-related mitochondrial dysfunction in sarcopenia","volume":"21","author":"Ferri","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-016-0709-0","article-title":"Nutrition, frailty, and sarcopenia","volume":"29","author":"Cruz-Jentoft","year":"2017","journal-title":"Aging Clin Exp Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-16-0603","article-title":"Aging human body: changes in bone, muscle and body fat with consequent changes in nutrient intake","volume":"234","author":"JafariNasabian","year":"2017","journal-title":"J Endocrinol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering8110168","article-title":"Advanced glycation end-products in skeletal muscle aging","volume":"8","author":"Olson","year":"2021","journal-title":"Bioengineering"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2022.111744","article-title":"Advanced glycation end products in skeletal muscle health and sarcopenia: a systematic review of observational studies","volume":"209","author":"Granic","year":"2023","journal-title":"Mech Ageing Dev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00592-022-01883-2","article-title":"Diabetic sarcopenia: metabolic and molecular appraisal","volume":"59","author":"Giha","year":"2022","journal-title":"Acta Diabetol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/jhbp.70041","article-title":"Integrative genomics reveals causal pleiotropy and therapeutic opportunities at the interface of acute pancreatitis and infection","volume":"33","author":"Zou","year":"2026","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/s12967-025-06568-2","article-title":"Post-genome-wide association study dissects genetic vulnerability and risk gene expression of Sj\u00f6gren\u2019s disease for cardiovascular disease","volume":"23","author":"Yi","year":"2025","journal-title":"J Transl Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s12967-025-06465-8","article-title":"Genomic structural equation modeling elucidates the shared genetic architecture of allergic disorders","volume":"23","author":"Ruan","year":"2025","journal-title":"J Transl Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2021.104437","article-title":"The vicious cycle in the development of diabetes mellitus and sarcopenia in older persons","volume":"95","author":"Chen","year":"2021","journal-title":"Arch Gerontol Geriatr"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020847","article-title":"Skeletal muscle microvascular dysfunction in obesity-related insulin resistance: pathophysiological mechanisms and therapeutic perspectives","volume":"23","author":"Ugwoke","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cmet.2012.11.012","article-title":"Vascular complications of diabetes: mechanisms of injury and protective factors","volume":"17","author":"Rask-Madsen","year":"2013","journal-title":"Cell Metab"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1289537","article-title":"Ubiquitin-proteasome pathway in skeletal muscle atrophy","volume":"14","author":"Pang","year":"2023","journal-title":"Front Physiol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.108.179697","article-title":"Oxidized low-density lipoprotein and atherosclerosis","volume":"30","author":"Steinberg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glw055","article-title":"Low hemoglobin concentrations are associated with sarcopenia, physical performance, and disability in older Australian men in cross-sectional and longitudinal analysis: the Concord Health and Ageing in Men Project","volume":"71","author":"Hirani","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1424227","article-title":"Association between sarcopenia and hemoglobin level: a systematic review and meta-analysis","volume":"11","author":"Wang","year":"2024","journal-title":"Front Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"771","DOI":"10.12290\/xhyxzz.2024-0347","article-title":"Guideline for the management of diabetes mellitus in the elderly in China (2024 edition)","volume":"15","year":"2024","journal-title":"Med J Peking Union Med Coll Hosp"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.783363","article-title":"Sarcopenia is associated with a risk of mortality in people with type 2 diabetes mellitus","volume":"12","author":"Takahashi","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.12290\/xhyxzz.2024-0287","article-title":"Impact of sarcopenia on long-term outcomes in elderly inpatients with type 2 diabetes mellitus: a prospective cohort study","volume":"15","author":"Zhang","year":"2024","journal-title":"Med J Peking Union Med Coll Hosp"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1933664\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:30:56Z","timestamp":1789101056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1933664\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":58,"alternative-id":["10.3389\/fendo.2026.1933664"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1933664","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"article-number":"1933664"}}